Dicationic lipophosphoramidates as DNA carriers.

Area of Science:

• Biomaterials Science
• Gene Therapy
• Medicinal Chemistry

Background:

• Lipophosphoramidates are investigated for their potential in gene delivery systems.
• Developing efficient and safe non-viral vectors is crucial for gene therapy applications.

Purpose of the Study:

• To synthesize and evaluate lipophosphoramidates with dicationic polar heads for gene transfer activity.
• To compare the efficacy of dicationic lipophosphoramidates against their monocationic counterparts.

Main Methods:

• Synthesis of lipophosphoramidates with dicationic polar heads.
• Physicochemical characterization including particle size and zeta potential measurements.
• In vitro gene transfer assays using A542 and HeLa cell lines, and cytotoxicity assessment via chemiluminescent assay.

Main Results:

• Dicationic lipophosphoramidates were successfully synthesized and characterized.
• Physicochemical properties were evaluated, alongside gel retardation assays.
• In vitro studies demonstrated gene transfer activity in A542 and HeLa cells.
• Cytotoxicity was assessed, with dicationic lipophosphoramidates showing potential.

Conclusions:

• Dicationic lipophosphoramidates represent a promising class of non-viral gene delivery vectors.
• These compounds offer a potentially advantageous alternative to existing monocationic analogues.
• Further research into dicationic lipophosphoramidates could advance gene therapy strategies.